227 related articles for article (PubMed ID: 17694067)
1. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
[TBL] [Abstract][Full Text] [Related]
3. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
[TBL] [Abstract][Full Text] [Related]
4. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.
Küçük C; Hu X; Iqbal J; Gaulard P; Klinkebiel D; Cornish A; Dave BJ; Chan WC
Am J Pathol; 2013 Jan; 182(1):49-55. PubMed ID: 23142381
[TBL] [Abstract][Full Text] [Related]
5. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
[TBL] [Abstract][Full Text] [Related]
6. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
[TBL] [Abstract][Full Text] [Related]
7. HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
[TBL] [Abstract][Full Text] [Related]
8. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
[TBL] [Abstract][Full Text] [Related]
9. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
[TBL] [Abstract][Full Text] [Related]
11. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
Goka ET; Lippman ME
Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
[TBL] [Abstract][Full Text] [Related]
12. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
[TBL] [Abstract][Full Text] [Related]
13. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
[TBL] [Abstract][Full Text] [Related]
14. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
[TBL] [Abstract][Full Text] [Related]
15. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.
Tortola L; Nitsch R; Bertrand MJM; Kogler M; Redouane Y; Kozieradzki I; Uribesalgo I; Fennell LM; Daugaard M; Klug H; Wirnsberger G; Wimmer R; Perlot T; Sarao R; Rao S; Hanada T; Takahashi N; Kernbauer E; Demiröz D; Lang M; Superti-Furga G; Decker T; Pichler A; Ikeda F; Kroemer G; Vandenabeele P; Sorensen PH; Penninger JM
Cell Rep; 2016 May; 15(7):1481-1492. PubMed ID: 27160902
[TBL] [Abstract][Full Text] [Related]
16. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
[TBL] [Abstract][Full Text] [Related]
17. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.
Jia W; Deng Z; Zhu J; Fu W; Zhu S; Zhang LY; Hu J; Wang F; Xia H; Liu GC; He J
Cancer Invest; 2017 Nov; 35(10):633-638. PubMed ID: 29243987
[TBL] [Abstract][Full Text] [Related]
18. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
[TBL] [Abstract][Full Text] [Related]
19. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
J Virol; 2019 May; 93(9):. PubMed ID: 30787155
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
